{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:28:47Z","timestamp":1792812527966,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032539","name":"Gedeon Richter","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032539","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002910","name":"F\u00e9d\u00e9ration Wallonie-Bruxelles","doi-asserted-by":"publisher","award":["Medicines360"],"award-info":[{"award-number":["Medicines360"]}],"id":[{"id":"10.13039\/501100002910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031579","name":"Mithra Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012781","name":"Merck Sharp and Dohme K.K.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016132","name":"R\u00e9gion wallonne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016132","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rpth.2025.103285","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:17:09Z","timestamp":1765037829000},"page":"103285","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9195-304X","authenticated-orcid":false,"given":"Laure","family":"Morimont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell D.","family":"Creinin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulysse","family":"Gaspard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Foidart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Douxfils","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2025.103285_bib1","article-title":"Combined oral contraceptives: venous thrombosis","volume":"2014","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.rpth.2025.103285_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103285_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.rpth.2025.103285_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4236\/ojog.2017.71003","article-title":"Contraception and venous thromboembolism: risk factors and clinical considerations","volume":"7","author":"Waddington","year":"2017","journal-title":"Open J Obstet Gynecol"},{"key":"10.1016\/j.rpth.2025.103285_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.contraception.2024.110727","article-title":"Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: a disproportionality analysis of the Eudravigilance database","volume":"142","author":"Didembourg","year":"2025","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2025.103285_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1428597","article-title":"Are natural estrogens used in contraception at lower risk of venous thromboembolism than synthetic ones? A systematic literature review and meta-analysis","volume":"15","author":"Douxfils","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rpth.2025.103285_bib8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/13625187.2021.1987410","article-title":"Prospective controlled cohort study on the safety of a monophasic oral contraceptive containing nomegestrol acetate (2.5mg) and 17beta-oestradiol (1.5mg) (PRO-E2 study): risk of venous and arterial thromboembolism","volume":"26","author":"Reed","year":"2021","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.rpth.2025.103285_bib9","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/s-0038-1653788","article-title":"Sensitivity to activated protein C; influence of oral contraceptives and sex","volume":"73","author":"Henkens","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103285_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1365-2141.1995.tb05323.x","article-title":"Resistance to activated protein C in healthy women taking oral contraceptives","volume":"91","author":"Olivieri","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2025.103285_bib11","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1111\/j.1538-7836.2005.01430.x","article-title":"Determinants of the APTT- and ETP-based APC sensitivity tests","volume":"3","author":"de Visser","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103285_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thromres.2020.08.006","article-title":"Letter to the Editors-in-Chief in response to the article of Abou-Ismail, et al. entitled \u201cEstrogen and thrombosis: a bench to bedside review\u201d (Thrombosis Research 192 (2020) 40\u201351)","volume":"193","author":"Morimont","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2025.103285_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.rpth.2025.103285_bib14","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0040-1714140","article-title":"Oral contraceptives and venous thromboembolism: focus on testing that may enable prediction and assessment of the risk","volume":"46","author":"Douxfils","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103285_bib15","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1055\/s-0042-1753511","article-title":"Laboratory testing for the evaluation of phenotypic activated protein C resistance","volume":"48","author":"Morimont","year":"2022","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.rpth.2025.103285_bib16","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jtha.2022.10.014","article-title":"Factor V Leiden-independent activated protein C resistance: communication from the plasma coagulation inhibitors subcommittee of the International Society on Thrombosis and Haemostasis Scientific and Standardisation Committee","volume":"21","author":"Moore","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103285_bib17","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1515\/cclm-2019-0471","article-title":"Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women: an unmet clinical and regulatory need","volume":"58","author":"Douxfils","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.rpth.2025.103285_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2022.100021","article-title":"Hormonal therapies and venous thrombosis: estrogen matters!","volume":"7","author":"Morimont","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103285_bib19","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.rpth.2025.103285_bib20","doi-asserted-by":"crossref","DOI":"10.15761\/FWH.1000178","article-title":"Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: results from the extended INAS-SCORE study","volume":"5","author":"Dinger","year":"2020","journal-title":"Frontiers in Women\u2019s Health"},{"key":"10.1016\/j.rpth.2025.103285_bib21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1160\/TH05-10-0685","article-title":"Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT)","volume":"95","author":"Haidl","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103285_bib22","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1538-7836.2012.04828.x","article-title":"The relationship between body mass index, activated protein C resistance and risk of venous thrombosis","volume":"10","author":"Christiansen","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.rpth.2025.103285_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/13625180008500402","article-title":"The effect of age, body mass index, smoking, and general health on the risk of venous thromboembolism in users of combined oral contraceptives","volume":"5","author":"Nightingale","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.rpth.2025.103285_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/13625187.2015.1050091","article-title":"Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: a literature review","volume":"20","author":"Lete","year":"2015","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.rpth.2025.103285_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2024.28778","article-title":"Contemporary hormonal contraception and risk of venous thromboembolism","volume":"333","author":"Yonis","year":"2025","journal-title":"JAMA"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037925006090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:55:53Z","timestamp":1778896553000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037925006090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2475037925006090"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103285","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting venous thromboembolism risk from endogenous thrombin potential-based normalized activated protein C sensitivity ratio assay: toward early assessment of combined oral contraceptives","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2025.103285","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"103285"}}